Arixtra (fondaparinux sodium)

**Product type:** Human Prescription Drug

**Active ingredient:** FONDAPARINUX SODIUM

**Strength:** 5 mg/.4mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Mylan Institutional LLC

**Marketing category:** NDA (NDA021345)

**Pharmacologic class:** Factor Xa Inhibitor [EPC], Factor Xa Inhibitors [MoA]